COMP <GO>
TECH vs MRK // RETURN ON INVESTED CAPITAL (ROIC)
Bio-Techne Corp (NASDAQ) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: TECH 5
— MRK 10
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: MRK
LAST: $72.66 (-0.07%) • MKT CAP: $11.40B
roic
3.40%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
roic
20.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TECH VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TECH | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 64.80% | 74.80% | -10.00 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 3.40% | 20.70% | -17.30 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 91.3x | 15.3x | +76.00 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 2.25% | 3.42% | -1.17 | MRK | /fcf-yield <GO> |
| Operating Margin | 8.40% | 34.30% | -25.90 | MRK | /operating-margins <GO> |
| Net Profit Margin | 6.00% | 28.10% | -22.10 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 5.20% | 1.30% | +3.90 | TECH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.44% | 2.26% | -1.82 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.12 | 5.19 | +1.93 | TECH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | TECH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.60% | -0.10 | TECH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.2 | 56.9 | +0.34 | TECH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 0.92 | -0.04 | MRK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 18.4x | +121.60 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.40B | $361.02B | -$349.62B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TECH REV | MRK REV | TECH GROSS % | MRK GROSS % | TECH FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.22B | $65.01B | 64.8% | 74.8% | $256.6M | $12.36B |
| FY 2024 | $1.16B | $64.17B | 66.4% | 76.3% | $236.1M | $18.10B |
| FY 2023 | $1.14B | $60.12B | 44.0% | 44.0% | $203.2M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TECH // BETA 0.88
MRK // BETA 0.92